Open Access Open Access  Restricted Access Subscription or Fee Access

The effects of QuikClot Combat Gauze and Celox Rapid on hemorrhage control

Don Johnson, PhD, Michelle Johnson, DNP, CRNA


Objective: Compare QuikClot Combat Gauze (QCG) and Celox Rapid (CR) for initial hemostasis and over a 1-hour period.

Design: Experimental study.

Setting: Approved animal laboratory.

Subjects: Twenty-one Yorkshire swine.

Interventions: Subjects were randomly assigned to either the QCG (n = 11) or CR (n = 10) group. An arteriotomy was made in the right femoral artery with a 6-mm vascular punch. Bleeding was allowed for 45 seconds. QCG or CR was applied followed by firm pressure for 3 minutes according to Committee on Tactical Combat Casualty Care guidelines. A 10-pound weight simulating a pressure dressing was applied, and the wound was observed for 1 hour. Dressing failure was bleeding > 2 percent of blood volume.

Main outcome measures: Achievement and maintenance of hemostasis and amount of hemorrhage during observation. Odds of successful hemostasis.

Results: QCG was significantly better than CR in initial hemostasis (p = 0.049) and maintaining hemostasis over 1 hour (p = 0.020). One hundred percent of QCG subjects and 70 percent of CR subjects achieved initial hemostasis. During the 1-hour observation, one additional CR subject failed to maintain hemostasis. CR had significantly more hemorrhage than QCG during the 1-hour observation (p = 0.027). QCG had no bleeding compared to CR that had a mean of 162 ± 48 mL (standard error of mean) over 2 minutes. QCG had 15.9 times greater odds of success compared to CR over a period of 1 hour. Over the 1-hour observation time, 100 percent of QCG achieved hemostasis compared to 60 percent of CR.

Conclusions: QCG is more effective than CR.


QuikClot Combat Gauze, Celox Rapid, hemorrhage control, bleeding

Full Text:



Hendrickson RG, Horowitz BZ: Disaster preparedness. In Tintinalli JE, Stapczynski JS, Ma OJ, et al. (eds.): Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 9th ed. New York, NY: McGraw-Hill Education, 2018.

Johnson D, Westbrook DM, Phelps D, et al.: The effects of QuikClot Combat Gauze on hemorrhage control when used in a porcine model of lethal femoral injury. Am J Disaster Med. 2014; 9(4): 309-315.

Crawford N: Human Cost of Post 9/11 Wars: Lethality and Transparency. Providence, RI: Watson Institute of International and Public Affairs, Brown University, 2018.

Dowling MB, Chaturvedi A, MacIntire IC, et al.: Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine. Injury. 2016; 47(10): 2105-2109.

McCaughey BG, Garrick J, Carey LC, et al.: Naval Support Activity Hospital Da Nang combat casualty deaths January to June 1968. Mil Med. 1987; 152(6): 284-289.

Kelly JF, Ritenour AE, McLaughlin DF, et al.: Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma. 2008; 64(2 suppl): S21-S26; discussion S26-S27.

Carey ME: Analysis of wounds incurred by U.S. Army Seventh Corps personnel treated in Corps hospitals during Operation Desert Storm, February 20 to March 10, 1991. J Trauma. 1996; 40(3 suppl): S165-S169.

Eastridge BJ Mabry RL Seguin P, et al.: Death on the battlefield (2001-2011): Implications for the future of combat casualty care. J Trauma Acute Care Surg. 2012; 73(6)(suppl 5): S431-S437.

Lozano R, Naghavi M, Foreman K, et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-2128.

Schauer SG, April MD, Naylor JF, et al.: Prehospital application of hemostatic agents in Iraq and Afghanistan. Prehosp Emerg Care. 2018; 22(5): 614-623.

Schauer SG, Naylor JF, April MD, et al.: Prehospital resuscitation performed on hypotensive trauma patients in Afghanistan: The prehospital trauma registry experience. Mil Med. 2019; 184: e154-e157.

Kauvar DS, Dubick MA, Walters TJ, et al.: Systematic review of prehospital tourniquet use in civilian limb trauma. J Trauma Acute Care Surg. 2018; 84(5): 819-825.

Kauvar DS, Miller D, Walters TJ: Tourniquet use is not associated with limb loss following military lower extremity arterial trauma. J Trauma Acute Care Surg. 2018; 85(3): 495-499.

Johnson D, Bates S, Nukalo S, et al.: The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia. Ann Med Surg (Lond). 2014; 3(2): 21-25.

Cosgriff N, Moore EE, Sauaia A, et al.: Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma. 1997; 42(5): 857-861; discussion 861-852.

Heckbert SR, Vedder NB, Hoffman W, et al.: Outcome after hemorrhagic shock in trauma patients. J Trauma. 1998; 45(3): 545-549.

Sauaia A, Moore FA, Moore EE, et al.: Early predictors of postinjury multiple organ failure. Arch Surg. 1994; 129(1): 39-45.

Horst HM, Dlugos S, Fath JJ, et al.: Coagulopathy and intraoperative blood salvage (IBS). J Trauma. 1992; 32(5): 646-652; discussion 652-643.

Champion HR, Bellamy RF, Roberts CP, et al.: A profile of combat injury. J Trauma. 2003; 54(5 suppl): S13-S19.

Gegel B, Burgert J, Gasko J, et al.: The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model. Mil Med. 2012; 177(12): 1543-1547.

Johnson D Agee S Reed A, et al.: The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution. US Army Med Dep J. 2012: 36-39.

MedTrade Products Ltd.: Celox. Crewe, UK: MedTrade Products Ltd. Available at http://www.celoxmedical.com23. Accessed March 3, 2019.

QuikClot: Available at Accessed March 3, 2019.

Garcia-Blanco J, Gegel B, Burgert J, et al.: The effects of movement on hemorrhage when QuikClot(R) Combat Gauze is used in a hypothermic hemodiluted porcine model. J Spec Oper Med. 2015; 15(1): 57-60.

Kheirabadi BS, Scherer MR, Estep JS, et al.: Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma. 2009; 67(3): 450-459; discussion 459-460.

Ran Y, Hadad E, Daher S, et al.: QuikClot Combat Gauze use for hemorrhage control in military trauma: January 2009 Israel Defense Force experience in the Gaza Strip—A preliminary report of 14 cases. Prehosp Disaster Med. 2010; 25(6): 584-588.

Travers S, Dubourg O, Ribeiro Parenti L, et al.: [Prehospital use of haemostatic dressing QuikClot ACS + for hemorrhage control of a perineal trauma]. Ann Fr Anesth Reanim. 2012; 31(12): 969-971.

Zietlow JM, Zietlow SP, Morris DS, et al.: Prehospital use of hemostatic bandages and tourniquets: Translation from military experience to implementation in civilian trauma care. J Spec Oper Med. 2015; 15(2): 48-53.

Vilardo N, Feinberg J, Black J, et al.: The use of QuikClot combat gauze in cervical and vaginal hemorrhage. Gynecol Oncol Rep. 2017; 21: 114-116.

Roberts JS, Niu J, Pastor-Cervantes JA: Comparison of hemostasis times with a kaolin-based hemostatic pad (QuikClot Radial) vs mechanical compression (TR Band) following transradial access: A pilot prospective study. J Invasive Cardiol. 2017; 29(10): 328-334.

Devlin JJ, Kircher S, Kozen BG, et al.: Comparison of ChitoFlex(R), CELOX, and QuikClot(R) in control of hemorrhage. J Emerg Med. 2011; 41(3): 237-245.

Rhee P, Brown C, Martin M, et al.: QuikClot use in trauma for hemorrhage control: Case series of 103 documented uses. J Trauma. 2008; 64(4): 1093-1099.

Mahajna A, Hirsh M, Krausz MM: Use of the hemostatic agent QuikClot for the treatment of massive splenic injury in a rat model. Eur Surg Res. 2007; 39(4): 251-257.

Schauer SG, April MD, Naylor JF, et al.: QuikClot(R) Combat Gauze(R) use by ground forces in Afghanistan: The Prehospital Trauma Registry experience. J Spec Oper Med. 2017; 17(2): 101-106.

Gegel BT, Austin PN, Johnson AD: An evidence-based review of the use of a combat gauze (QuikClot) for hemorrhage control. AANA J. 2013; 81(6): 453-458.

Kunio NR, Riha GM, Watson KM, et al.: Chitosan based advanced hemostatic dressing is associated with decreased blood loss in a swine uncontrolled hemorrhage model. Am J Surg. 2013; 205(5): 505-510.

Kheirabadi BS, Arnaud F, McCarron R, et al.: Development of a standard swine hemorrhage model for efficacy assessment of topical hemostatic agents. J Trauma. 2011; 71(1 suppl): S139-S146.

Clark JD, Gebhart GF, Gonder JC, et al.: Special report: The 1996 guide for the care and use of laboratory animals. ILAR J. 1997; 38(1): 41-48.

Tactical Combat Casualty Care Guidelines. August 1, 2018. Available at Accessed March 3, 2019.

Pusateri AE, Holcomb JB, Kheirabadi BS, et al.: Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006; 60(3): 674-682.

Pusateri AE, McCarthy SJ, Gregory KW, et al.: Effect of a chitosan- based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma. 2003; 54(1): 177-182.

Chung F, Abdullah HR, Liao P: STOP-Bang questionnaire: A practical approach to screen for obstructive sleep apnea. Chest. 2016; 149(3): 631-638.

De Castro GP, Dowling MB, Kilbourne M, et al.: Determination of efficacy of novel modified chitosan sponge dressing in a lethal arterial injury model in swine. J Trauma Acute Care Surg. 2012; 72(4): 899-907.



  • There are currently no refbacks.